Reference number : 236-2016-2017-Q2-00183, amendment number : , agreement type : G, recipient legal name : Sochett, Etienne B, recipient country : CA, recipient province : ON, recipient city : Toronto, recipient postal code : M5G 1X8, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 63136.0, agreement start date : 2016-08-01, agreement end date : 2018-07-31, description english : Rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations in the CYP24A1 gene, description french : Rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations in the CYP24A1 gene, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2016-17 to 2018-19), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2016-17 à 2018-19), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada